Purchase Order 75F40126P00070
- Not listed
- The U.S. Food and Drug Administration (FDA) awarded a purchase order contract to HK3 Lab S.R.L. (UEI: DTX4UPGGE425) on August 10, 2021, for artificial intelligence technical expert services. The contract carries a ceiling value of $155,000 and is structured as a firm fixed-price agreement with an ultimate completion date of August 9, 2026. Work will be performed in Jefferson, Arkansas. This contract award was not issued under any small business set-aside program. The solicitation was posted on...
- The Food and Drug Administration awarded a $233,900 delivery order to Vertosoft, LLC for DataRobot automated machine learning software on August 5, 2020, with completion targeted for August 9, 2021. This firm fixed-price contract, issued under the General Services Administration Multiple Award Schedule, was not designated as a set-aside and will be performed in Silver Spring, Maryland. Vertosoft, a HUBZone-certified small business based in Leesburg, Virginia, specializes as a value-added...
- The Department of Health and Human Services' Food and Drug Administration awarded a firm-fixed-price purchase order to Ursa Analytics, Inc., a small business contractor, to provide Microstructure Characterization with High Resolution Correlative Imaging and Artificial Intelligence Image Analytics for Solid Dosage Forms. The $179,678.00 contract has a completion date of November 4, 2022 and was awarded on May 5, 2020. This requirement was originally solicited as a total small business set-aside...
- The Food and Drug Administration awarded a $897,771.87 firm fixed-price purchase order to Agilent Technologies Inc. on May 3, 2023, for the procurement and delivery of one ion-mobility quadrupole time of flight (IM-QTOF) mass spectrometer. The instrument will be delivered to the FDA's facility in Silver Spring, Maryland, with an ultimate completion date of September 30, 2027. This procurement was conducted through open competition with no set-aside designation, based on Solicitation...
- The Food and Drug Administration issued a BPA call to Precise Software Solutions, Inc., an SBA-certified 8(a) Program participant, on April 13, 2022, for data scientist services in import risk screening and detection using artificial and machine learning, along with web content management system support services. The call carries a ceiling of $1,008,215 and was placed under the Multiple Award Schedule (MAS). Performance occurs in Rockville, Maryland, with an ultimate completion date of April 17,...
- The Food and Drug Administration awarded a $1,085,530 definitive contract to Genentech Inc. on September 11, 2025, for advanced research and development in regulatory science addressing hybrid randomized controlled trials in longitudinal settings, with emphasis on causal methodologies for managing diverse missing data patterns. The contract was issued under a Fiscal Year 2025 Broad Agency Announcement for Advanced Research and Development of Regulatory Science, which solicited proposals across...
- The Food and Drug Administration awarded a purchase order to Postnova Analytics Inc. for $62,229 to purchase a detector suite upgrade for a thermal field-flow fractionation system, including delivery, installation, and training. The award was issued on September 14, 2022, with a completion date of September 15, 2023. Work is performed in Silver Spring, Maryland. The procurement was issued under firm fixed-price terms without a small business set-aside, following a solicitation posted September...
- The Food and Drug Administration awarded a delivery order valued at $9.98 million to Systems Intelligence, LLC for an Electronic Records Retention Project task order. This firm fixed-price delivery order was issued on February 12, 2026, with an ultimate completion date of December 13, 2030, and will be performed in Rockville, Maryland. The contract carries no set-aside designation and represents work under Systems Intelligence's existing federal contracting vehicles with the FDA. Systems...
- The Department of Health and Human Services Food and Drug Administration awarded a $329,470 firm fixed price purchase order to Digim Solution LLC for image processing, modeling and simulation software. The solicitation sought a platform capable of image analysis, data management, computing resource management, quantitative data extraction, predictive simulation, and FDA 21 CFR Part 11 compliance to assess product quality attributes. Performance will take place in Woburn, Massachusetts through...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...
The Food and Drug Administration awarded a purchase order to Sentrysciences, Inc. valued at $55,000 on June 15, 2026 for an artificial intelligence and computational statistics platform to detect and classify protein aggregates in biosimilar drug products. Work is performed in Silver Spring, Maryland. The platform combines machine learning to generate morphological fingerprints of protein aggregates, differentiate particles by stress type and product, and employ neural network-based metric learning to characterize subvisible particles under 100 microns. The system must be compatible with Flow Imaging and Backgrounded Membrane Imaging data and employ statistical analysis tools including Euclidian distance and Kolmogorov-Smirnov test similarity scores. The contractor provides training for FDA staff on AI/ML application and result interpretation. Performance period is 12 months, with ultimate completion by June 14, 2027. The order originated from a full and open solicitation posted May 11, 2026 with quotes due May 26, 2026, and was awarded on a Lowest Price Technically Acceptable basis.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Artificial Intelligence and Computational Statistics Platform for Biosimilar Subvisible Characterization | FDA-75F40126Q00142 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 1/1 | 5/11/26, 3:58 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.0k | 6/11/26 |